Cited by 479Multiple Sclerosis Research StudiesAnimal testing and alternativesPeripheral Neuropathies and Disorders

The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.

How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis.

Steinman, Lawrence, Zamvil, Scott S.·2006·Annals of Neurology

DOI 10.1002/ana.20913

Open this paper in CoChat — free account

Abstract

In their Point of View entitled "Experimental Allergic Encephalomyelitis: A Misleading Model of Multiple Sclerosis," Sriram and Steiner(1) wrote, "The most disappointing aspect of EAE [experimental allergic encephalomyelitis] as a potential model for MS is its almost total inability to point toward a meaningful therapy or therapeutic approach for MS." Actually, EAE has led directly to the development of three therapies approved for use in multiple sclerosis (MS): glatiramer acetate, mitoxantrone, and natalizumab. Several new approaches to MS are in clinical trials based on positive indications in preclinical work relying on EAE. New clues to the pathogenesis of MS and new potential surrogate markers for MS are shown from research involving EAE when it is critically coupled with actual findings in MS. There are pitfalls in overreliance on the EAE model, or on any animal model for any human disease. Nevertheless, over the past 73 years, the EAE model has proved itself remarkably useful for aiding research on MS.

Integrity signals

Registry

Crossref · 10.1002/ana.20913

Cites

88 of 88 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis.
Polman, C., O'Connor, P., Havrdová, E., Hutchinson, M., Kappos, L., Miller, D. H., Phillips, J., Lublin, F., Giovannoni, G., Wajgt, A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa044397 · Cited by 3,293
Prevention of experimental autoimmune encephalomyelitis by antibodies against α4βl integrin
Yednock, T. A., Cannon, C., Fritz, L. C., Sánchez‐Madrid, F., Steinman, L., & Karin, N. (1992) · Nature · doi:10.1038/356063a0 · Cited by 1,737
Self-citation
Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosis
Johnson, K., Brooks, B., Cohen, J. A., Ford, C., Goldstein, J., Lisak, R., Myers, L., Panitch, H., Rose, J., Schiffer, R., et al. (1995) · Neurology · doi:10.1212/wnl.45.7.1268 · Cited by 1,667
Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis
Lock, C., Hermans, G., Pedotti, R., Brendolan, A., Schadt, E. E., Garren, H., Langer-Gould, A. M., Strober, S., Cannella, B., Allard, J. D., et al. (2002) · Nature Medicine · doi:10.1038/nm0502-500 · Cited by 1,659
Self-citation
The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors
Brinkmann, V., Davis, M. D., Heise, C. E., Albert, R., Cottens, S., Hof, R., Bruns, C., Prieschl, E. E., Baumruker, T., HIESTAND, P. C., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200176200 · Cited by 1,512
Natalizumab plus Interferon Beta-1a for Relapsing Multiple Sclerosis
Rudick, R. A., Stuart, W. H., Calabresi, P. A., Confavreux, C., Galetta, S. L., Radue, E. W., LUBLIN, F. D., Weinstock‐Guttman, B., Wynn, D. R., Lynn, F., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa044396 · Cited by 1,342
The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease
Youssef, S., Stüve, O., Patarroyo, J. C., Ruiz, P. J., Radosevich, J. L., Hur, E. M., Bravo, M., Mitchell, D. J., Sobel, R. A., Steinman, L., et al. (2002) · Nature · doi:10.1038/nature01158 · Cited by 1,096
Self-citation
TNF neutralization in MS
The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group (1999) · Neurology · doi:10.1212/wnl.53.3.457 · Cited by 1,068
The T Lymphocyte In Experimental Allergic Encephalomyelitis
Zamvil, S. S., & Steinman, L. (1990) · Annual Review of Immunology · doi:10.1146/annurev.iy.08.040190.003051 · Cited by 1,013
Self-citation

Flagged first, then by citations

Show all 88 references

Sorted by citations

Items 101–200 of 479

Isoflavones derived from plant raw materials: bioavailability, anti-cancer, anti-aging potentials, and microbiome modulation
Aboushanab, S. A., Khedr, S. M., Гетте, И. Ф., Danilova, I. G., Кольберг, Н. А., Ravishankar, G. A., Rao, A. R., & Kovaleva, E. G. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1946006 · Cited by 76
Genetic inactivation of the adenosine A2A receptor exacerbates brain damage in mice with experimental autoimmune encephalomyelitis
Yao, S., Li, Z.-Z., Huang, Q., Li, F., Wang, Z., Augusto, E., He, J., Wang, X., Chen, J., & Zheng, R. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07807.x · Cited by 75
A case for regulatory B cells in controlling the severity of autoimmune-mediated inflammation in experimental autoimmune encephalomyelitis and multiple sclerosis
Ray, A., Mann, M. K., Basu, S., & Dittel, B. N. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.10.037 · Cited by 73
IL‐23‐driven encephalo‐tropism and Th17 polarization during CNS‐inflammation in vivo
Gyülvészi, G., Haak, S., & Becher, B. (2009) · European Journal of Immunology · doi:10.1002/eji.200939305 · Cited by 73
Parent-of-origin effects in MS
Herrera, B. M., Ramagopalan, S. V., Lincoln, M. R., Orton, S. M., Chao, M., Sadovnick, A. D., & Ebers, G. C. (2008) · Neurology · doi:10.1212/01.wnl.0000312377.50395.00 · Cited by 73
Fabrication Principles and Their Contribution to the Superior In Vivo Therapeutic Efficacy of Nano-Liposomes Remote Loaded with Glucocorticoids
Avnir, Y., Turjeman, K., Tulchinsky, D., Sigal, A., Kizelsztein, P., Tzemach, D., Gabizon, A., & Barenholz, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025721 · Cited by 72
The Multitasking Mast Cell: Positive and Negative Roles in the Progression of Autoimmunity
Christy, A. L., & Brown, M. A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.5.2673 · Cited by 73
The Effects of Stressful Life Events on the Course of Multiple Sclerosis: A Review
Mitsonis, C., Potagas, C. M., Zervas, I. M., & Sfagos, K. (2009) · International Journal of Neuroscience · doi:10.1080/00207450802480192 · Cited by 73
Amyloid Fibrils Composed of Hexameric Peptides Attenuate Neuroinflammation
Kurnellas, M., Adams, C. M., Sobel, R. A., Steinman, L., & Rothbard, J. B. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005681 · Cited by 72
Self-citation
Are current disease‐modifying therapeutics in multiple sclerosis justified on the basis of studies in experimental autoimmune encephalomyelitis?
Farooqi, N., Gran, B., & Constantinescu, C. S. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06982.x · Cited by 69
Structural Insight into the Function of Myelin Basic Protein as a Ligand for Integrin αMβ2
Stapulionis, R., Oliveira, C. L. P., Gjelstrup, M. C., Pedersen, J. S., Hokland, M., Hoffmann, S. V., Poulsen, K., Jacobsen, C. B., & Vorup‐Jensen, T. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.6.3946 · Cited by 65
A Cannabigerol Derivative Suppresses Immune Responses and Protects Mice from Experimental Autoimmune Encephalomyelitis
Carrillo-Salinas, F. J., Navarrete, C. M., Mecha, M., Feliú, A., Collado, J. A., Cantarero, I., Bellido, M. L., Muñóz, E., & Guaza, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094733 · Cited by 66
A mouse model for testing remyelinating therapies
Bai, C. B., Sun, H. S., Roholt, A., Benson, E. K., Edberg, D. D., Medicetty, S., Dutta, R., Kidd, G. J., Macklin, W. B., & Trapp, B. D. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.06.033 · Cited by 68
Clinical, Pathological, and Immunologic Aspects of the Multiple Sclerosis Model in Common Marmosets (Callithrix jacchus)
Hart, B. A. ‘., & Massacesi, L. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31819f1d24 · Cited by 65
Cell-based interventions for neurologic conditions
Mathews, D., Sugarman, J., Bok, H., Blass, D. M., Coyle, J. T., Duggan, P., Finkel, J., Greely, H. T., Hillis, A. E., Höke, A., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000316436.13659.80 · Cited by 63
Modulation of inflammatory pathways by the immune cholinergic system
Nizri‏, E., & Brenner, T. (2011) · Amino Acids · doi:10.1007/s00726-011-1192-8 · Cited by 65
A Role for VAV1 in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
Jagodic, M., Colacios, C., Nohra, R. G., Dejean, A. S., Beyeen, A. D., Khademi, M., Casemayou, A., Lamouroux, L., Duthoit, C. T., Papapietro, O., et al. (2009) · Science Translational Medicine · doi:10.1126/scitranslmed.3000278 · Cited by 66
Fingolimod reduces neuropathic pain behaviors in a mouse model of multiple sclerosis by a sphingosine-1 phosphate receptor 1-dependent inhibition of central sensitization in the dorsal horn
Doolen, S., Iannitti, T., Donahue, R. R., Shaw, B. C., Grachen, C. M., & Taylor, B. K. (2017) · Pain · doi:10.1097/j.pain.0000000000001106 · Cited by 65
Bone Marrow-Derived Mast Cells Accumulate in the Central Nervous System During Inflammation but Are Dispensable for Experimental Autoimmune Encephalomyelitis Pathogenesis
Bennett, J. L., Blanchet, M., Zhao, L., Zbytnuik, L. D., Antignano, F., Gold, M., Kubes, P., & McNagny, K. M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801485 · Cited by 63
CD44 Deficiency Contributes to Enhanced Experimental Autoimmune Encephalomyelitis
Flynn, K. M., Michaud, M., & Madri, J. A. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.01.003 · Cited by 62
C-Phycocyanin ameliorates experimental autoimmune encephalomyelitis and induces regulatory T cells
Pentón-Rol, G., Martínez-Sánchez, G., Cervantes-Llanos, M., Lagumersindez-Denis, N., Acosta-Medina, E. F., Falcón-Cama, V., Alonso-Ramírez, R., Valenzuela-Silva, C., Rodríguez-Jiménez, E., Llópiz-Arzuaga, A., et al. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2010.10.001 · Cited by 61
Molecular Mechanisms of Oligodendrocyte Injury in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
Patel, J., & Balabanov, R. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms130810647 · Cited by 61
Neuroprotection in multiple sclerosis: A therapeutic challenge for the next decade
van der Walt, A., Butzkueven, H., Kolbe, S., Marriott, M. P., Alexandrou, E., Gresle, M. M., Egan, G. F., & Kilpatrick, T. J. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.01.006 · Cited by 61
Role of T cells and dendritic cells in glomerular immunopathology
Kurts, C., Heymann, F., Lukacs‐Kornek, V., Boor, P., & Floege, J. (2007) · Seminars in Immunopathology · doi:10.1007/s00281-007-0096-x · Cited by 59
Clinical Characteristics and Treatment of MOG-IgG–Associated Optic Neuritis
Tajfirouz, D. A., Bhatti, M. T., & Chen, J. J.-W. (2019) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-019-1014-z · Cited by 60
Metformin as a Potential Agent in the Treatment of Multiple Sclerosis
Dziedzic, A., Saluk, J., Miller, E. D., & Bijak, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21175957 · Cited by 62
The CD8 T Cell in Multiple Sclerosis: Suppressor Cell Or Mediator of Neuropathology?
Johnson, A. J., Suidan, G. L., Mcdole, J. R., & Pirko, I. (2007) · International review of neurobiology · doi:10.1016/s0074-7742(07)79004-9 · Cited by 59
Toxins Targeting the KV1.3 Channel: Potential Immunomodulators for Autoimmune Diseases
Zhao, Y., Huang, J., Yuan, X., Peng, B., Liu, W., Han, S. H., & He, X. (2015) · Toxins · doi:10.3390/toxins7051749 · Cited by 58
Arctigenin Suppress Th17 Cells and Ameliorates Experimental Autoimmune Encephalomyelitis Through AMPK and PPAR-γ/ROR-γt Signaling
Li, W., Zhang, Z., Zhang, K., Xue, Z., Li, Y., Zhang, Z., Zhang, L., Gu, C., Zhang, Q., Hao, J., et al. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9462-1 · Cited by 57
Combined treatment with atorvastatin and minocycline suppresses severity of EAE
Luccarini, I., Ballerini, C., Biagioli, T., Biamonte, F., Bellucci, A., Rosi, M. C., Grossi, C., Massacesi, L., & Casamenti, F. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.01.022 · Cited by 58
Chaperone Activity of Small Heat Shock Proteins Underlies Therapeutic Efficacy in Experimental Autoimmune Encephalomyelitis*
Kurnellas, M. P., Brownell, S., Su, L., Malkovskiy, A., Rajadas, J., Dolganov, G., Chopra, S., Schoolnik, G., Sobel, R., Webster, J., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.371229 · Cited by 62
Self-citation
Multiple sclerosis
Cusick, M. F., Libbey, J. E., & Fujinami, R. S. (2013) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e328362004d · Cited by 58
Neural Stem Cell-Based Regenerative Approaches for the Treatment of Multiple Sclerosis
Xiao, J., Yang, R., Biswas, S., Zhu, Y., Qin, X., Zhang, M., Zhai, L., Luo, Y., He, X., Mao, C., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0566-7 · Cited by 60
Microglial Lectins in Health and Neurological Diseases
Siew, J. J., & Chern, Y. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00158 · Cited by 63
Experimental Autoimmune Encephalomyelitis in the Common Marmoset, a Bridge Between Rodent EAE and Multiple Sclerosis for Immunotherapy Development
Kap, Y. S., Laman, J. D., & Hart, B. A. ‘. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9178-y · Cited by 61
Blockade of cytosolic phospholipase A2α prevents experimental autoimmune encephalomyelitis and diminishes development of Th1 and Th17 responses
Marušić, S., Thakker, P., Pelker, J. W., Stedman, N. L., Lee, K. L., McKew, J. C., Han, L.-X., Xu, X., Wolf, S. F., Borey, A. J., et al. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.08.012 · Cited by 57
Extracellular vesicle fibrinogen induces encephalitogenic CD8+ T cells in a mouse model of multiple sclerosis
Willis, C. M., Nicaise, A. M., Ménoret, A., Ryu, J. K., Mendiola, A. S., Jellison, E. R., Givogri, M. I., Han, D. K. M., Bongarzone, E. R., Akassoglou, K., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1816911116 · Cited by 56
Revisiting the Pathoetiology of Multiple Sclerosis: Has the Tail Been Wagging the Mouse?
Sen, M. K., Almuslehi, M. S. M., Shortland, P. J., Coorssen, J. R., & Mahns, D. A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.572186 · Cited by 59
Chemokine-mediated redirection of T cells constitutes a critical mechanism of glucocorticoid therapy in autoimmune CNS responses
Schweingruber, N., Fischer, H. J., Fischer, L., van den Brandt, J., Karabinskaya, A., Labi, V., Villunger, A., Kretzschmar, B., Huppke, P., Simons, M., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1248-4 · Cited by 54
Immune modulation by Lacto-N-fucopentaose III in experimental autoimmune encephalomyelitis
Zhu, B., Trikudanathan, S., Zozulya, A. L., Sandoval-Garcia, C., Kennedy, J. K., Atochina, O., Norberg, T., Castagner, B., Seeberger, P. H., Fábry, Z., et al. (2011) · Clinical Immunology · doi:10.1016/j.clim.2011.12.006 · Cited by 53
Von-Willebrand Factor Influences Blood Brain Barrier Permeability and Brain Inflammation in Experimental Allergic Encephalomyelitis
Noubade, R., del Río, R., McElvany, B. D., Zachary, J. F., Millward, J. M., Wagner, D. D., Offner, H., Blankenhorn, E. P., & Teuscher, C. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.080001 · Cited by 55
Alcohol shifts gut microbial networks and ameliorates a murine model of neuroinflammation in a sex-specific pattern
Caslin, B., Maguire, C. P., Karmakar, A., Mohler, K., Wylie, D., & Melamed, E. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1912359116 · Cited by 54
Connexin 43/47 channels are important for astrocyte/oligodendrocyte cross-talk in myelination and demyelination
Basu, R., & Sarma, J. D. (2018) · Journal of Biosciences · doi:10.1007/s12038-018-9811-0 · Cited by 54
Early MRI changes in a mouse model of multiple sclerosis are predictive of severe inflammatory tissue damage
Nessler, S., Boretius, S., Stadelmann, C., Bittner, A., Merkler, D., Hartung, H. ‐., Michaelis, T., Brück, W., Frahm, J., Sommer, N., et al. (2007) · Brain · doi:10.1093/brain/awm105 · Cited by 54
Effects of exercise in experimental autoimmune encephalomyelitis (an animal model of multiple sclerosis)
Klaren, R. E., Motl, R. W., Woods, J. A., & Miller, S. D. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.06.014 · Cited by 52
Bioenergetics profile of CD4 + T cells in relapsing remitting multiple sclerosis subjects
Riccardis, L. D., Rizzello, A., Ferramosca, A., Urso, E., Robertis, F. D., Danieli, A., Giudetti, A. M., Trianni, G., Zara, V., & Maffia, M. (2015) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2015.02.015 · Cited by 52
The Primate EAE Model Points at EBV-Infected B Cells as a Preferential Therapy Target in Multiple Sclerosis
Hart, B. A. ‘., Jagessar, S. A., Haanstra, K. G., Verschoor, E. J., Laman, J. D., & Kap, Y. S. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00145 · Cited by 52
Therapeutic laquinimod treatment decreases inflammation, initiates axon remyelination, and improves motor deficit in a mouse model of multiple sclerosis
Moore, S. M., Khalaj, A. J., Yoon, J., Patel, R., Hannsun, G., Yoo, T. S., Manda, S. V., Martinez‐Torres, L., Hayardeny, L., & Tiwari-Woodruff, S. K. (2013) · Brain and Behavior · doi:10.1002/brb3.174 · Cited by 53
The problems and promises of research into human immunology and autoimmune disease
Roep, B. O., Buckner, J. H., Sawcer, S. J., Toes, R. E. M., & Zipp, F. (2012) · Nature Medicine · doi:10.1038/nm.2626 · Cited by 52
Mouse model mimics multiple sclerosis in the clinico‐radiological paradox
Wuerfel, J. T., Tysiak, E., Prozorovski, T., Smyth, M., Mueller, S. G., Schnorr, J., Taupitz, M., & Zipp, F. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05644.x · Cited by 51
Platelet-Activating Factor Production in the Spinal Cord of Experimental Allergic Encephalomyelitis Mice via the Group IVA Cytosolic Phospholipase A2-Lyso-PAFAT Axis
Kihara, Y., Yanagida, K., Masago, K., Kita, Y., Hishikawa, D., Shindou, H., Ishii, S., & Shimizu, T. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.5008 · Cited by 51
Stage-Specific Immune Dysregulation in Multiple Sclerosis
Segal, B. M. (2014) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2014.0025 · Cited by 49
The Nucleotide-binding Leucine-rich Repeat (NLR) Family Member NLRX1 Mediates Protection against Experimental Autoimmune Encephalomyelitis and Represses Macrophage/Microglia-induced Inflammation
Eitas, T. K., Chou, W.-C., Wen, H., Gris, D., Robbins, G. R., Brickey, W. J., Oyama, Y., & Ting, J. P. ‐. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.533034 · Cited by 51
Advancing Cardiovascular, Neurovascular, and Renal Magnetic Resonance Imaging in Small Rodents Using Cryogenic Radiofrequency Coil Technology
Niendorf, T., Pohlmann, A., Reimann, H. M., Waiczies, H., Peper, E. S., Huelnhagen, T., Seeliger, E., Schreiber, A., Kettritz, R., Strobel, K., et al. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00255 · Cited by 48
Acetylcholinesterase inhibitors and cholinergic modulation in Myasthenia Gravis and neuroinflammation
Brenner, T., Nizri‏, E., Irony-Tur-Sinai, M., Hamra‐Amitay, Y., & Wirguin, I. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.05.022 · Cited by 47
Protective and therapeutic role of 2-carba-cyclic phosphatidic acid in demyelinating disease
Yamamoto, S., Yamashina, K., Ishikawa, M., Gotoh, M., Yagishita, S., Iwasa, K., Maruyama, K., Murakami‐Murofushi, K., & Yoshikawa, K. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0923-5 · Cited by 48
Synergistic effects of atorvastatin and all-trans retinoic acid in ameliorating animal model of multiple sclerosis
Froushani, S. M. A., Delirezh, N., Hobbenaghi, R., & Mosayebi, G. (2013) · Immunological Investigations · doi:10.3109/08820139.2013.825269 · Cited by 47
Gene therapy with mesenchymal stem cells expressing IFN‐ß ameliorates neuroinflammation in experimental models of multiple sclerosis
Marín-Bañasco, C., Benabdellah, K., Melero‐Jerez, C., Oliver‐Martos, B., Pinto-Medel, M. J., Hurtado-Guerrero, I., de Castro, F., Clemente, D., Fernández, Ó., Martı́n, F., et al. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13674 · Cited by 47
Epidermal Growth Factor in the CNS: A Beguiling Journey from Integrated Cell Biology to Multiple Sclerosis. An Extensive Translational Overview
Scalabrino, G. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00989-x · Cited by 49
Current Status of the Immunomodulation and Immunomediated Therapeutic Strategies for Multiple Sclerosis
Chen, S., Wang, A. Y. L., Fan, H., Lo, W., Wang, C., & Sytwu, H. (2011) · Clinical and Developmental Immunology · doi:10.1155/2012/970789 · Cited by 46
Multiple Sclerosis: Myeloperoxidase Immunoradiology Improves Detection of Acute and Chronic Disease in Experimental Model
Pulli, B., Buré, L., Wojtkiewicz, G. R., Iwamoto, Y., Ali, M. Y. J., Li, D., Schob, S., Hsieh, K. L., Jacobs, A. H., & Chen, J. W. (2014) · Radiology · doi:10.1148/radiol.14141495 · Cited by 48
Endogenous Opioids Regulate Expression of Experimental Autoimmune Encephalomyelitis: A New Paradigm for the Treatment of Multiple Sclerosis
Zagon, I. S., Rahn, K. A., Turel, A. P., & McLaughlin, P. J. (2009) · Experimental Biology and Medicine · doi:10.3181/0906-rm-189 · Cited by 46
Stat4 Isoforms Differentially Regulate Inflammation and Demyelination in Experimental Allergic Encephalomyelitis
Mo, C., Chearwae, W., O’Malley, J. T., Adams, S. M., Kanakasabai, S., Walline, C. C., Stritesky, G. L., Good, S. R., Perumal, N. B., Kaplan, M. H., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5681 · Cited by 45
Platelet Depletion is Effective in Ameliorating Anxiety-Like Behavior and Reducing the Pro-Inflammatory Environment in the Hippocampus in Murine Experimental Autoimmune Encephalomyelitis
Kocovski, P., Jiang, X., D’Souza, C. S., Li, Z., Dang, P. T., Wang, X., Chen, W., Peter, K., Hale, M. W., & Orian, J. M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8020162 · Cited by 44
Block of neural Kv1.1 potassium channels for neuroinflammatory disease therapy
Béraud, E., Viola, A., Regaya, I., Sylviane Confort-gouny, A., Siaud, P., Ibarrola, D., Fur, Y. L., Barbaria, J., Pellissier, J., Sabatier, J., et al. (2006) · Annals of Neurology · doi:10.1002/ana.21007 · Cited by 44
Astragaloside IV regulates differentiation and induces apoptosis of activated CD4+ T cells in the pathogenesis of experimental autoimmune encephalomyelitis
Liu, Y., Xing, F., Han, X., Li, Q., Wu, H., Shi, H., Wang, Z., Huang, F., & Wu, X. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.10.024 · Cited by 44
The role of animal models in evaluating reasonable safety and efficacy for human trials of cell-based interventions for neurologic conditions
Regenberg, A., Mathews, D., Blass, D. M., Bok, H., Coyle, J., Duggan, P., Faden, R., Finkel, J., Gearhart, J. D., Hillis, A., et al. (2008) · Journal of Cerebral Blood Flow and Metabolism · doi:10.1038/jcbfm.2008.98 · Cited by 43
γδ T cells in EAE: Early trafficking events and cytokine requirements
Wohler, J. E., Smith, S. S., Zinn, K. R., Bullard, D., & Barnum, S. R. (2009) · European Journal of Immunology · doi:10.1002/eji.200839176 · Cited by 44
Autoantibodies to Non-myelin Antigens as Contributors to the Pathogenesis of Multiple Sclerosis
Levin, M. C. (2013) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000148 · Cited by 43
Treatment with tanshinone IIA suppresses disruption of the blood-brain barrier and reduces expression of adhesion molecules and chemokines in experimental autoimmune encephalomyelitis
Yang, X., Yan, J., & Feng, J. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.12.014 · Cited by 43
Chrysin suppresses human CD14+ monocyte-derived dendritic cells and ameliorates experimental autoimmune encephalomyelitis
Zhang, K., Ge, Z., Xue, Z., Huang, W., Mei, M., Zhang, Q., Li, Y., Li, W., Zhang, Z., Zhang, Z., et al. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.08.017 · Cited by 42
The flavonoid Baicalein attenuates cuprizone-induced demyelination via suppression of neuroinflammation
Hashimoto, M., Yamamoto, S., Iwasa, K., Yamashina, K., Ishikawa, M., Maruyama, K., Bosetti, F., & Yoshikawa, K. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.09.007 · Cited by 41
Experimental Autoimmune Encephalomyelitis Mediated by CD8+ T Cells
Ji, Q., & Goverman, J. M. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1394.017 · Cited by 41
Neuroprotection in a Novel Mouse Model of Multiple Sclerosis
Lidster, K., Jackson, S. J., Ahmed, Z., Munro, P., Coffey, P. J., Giovannoni, G., Baker, M. D., & Baker, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079188 · Cited by 39
Acute treatment with valproic acid and l-thyroxine ameliorates clinical signs of experimental autoimmune encephalomyelitis and prevents brain pathology in DA rats
Castelo‐Branco, G., Stridh, P., Guerreiro‐Cacais, A. O., Adzemovic, M. Z., Falcão, A. M., Marta, M., Berglund, R., Gillett, A., Hamza, K. H., Lassmann, H., et al. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.08.019 · Cited by 39
Immunologic Aspects of Multiple Sclerosis
Boppana, S., Huang, H., Ito, K., & Dhib-Jalbut, S. S. (2011) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20249 · Cited by 40
Mitomycin C-treated dendritic cells inactivate autoreactive T cells: Toward the development of a tolerogenic vaccine in autoimmune diseases
Terness, P., Oelert, T., Ehser, S., Chuang, J. J., Lahdou, I., Kleist, C., Velten, F., Hämmerling, G. J., Arnold, B., & Opelz, G. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807185105 · Cited by 39
Macrophages in neuroinflammation: role of the renin-angiotensin-system
Hammer, A., Stegbauer, J., & Linker, R. A. (2017) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-017-1942-x · Cited by 40
ApoE-Deficient Promotes Blood–Brain Barrier Disruption in Experimental Autoimmune Encephalomyelitis via Alteration of MMP-9
Zheng, M., Wei, J., Tang, Y., Yang, C., Wei, Y., Yin, X., & Liu, Q. (2014) · Journal of Molecular Neuroscience · doi:10.1007/s12031-014-0291-x · Cited by 37
Quantification of Myelin and Axon Pathology During Relapsing Progressive Experimental Autoimmune Encephalomyelitis in the Biozzi ABH Mouse
Jackson, S. J., Lee, J., Nikodemova, M., Fabry, Z., & Duncan, I. D. (2009) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/nen.0b013e3181a41d23 · Cited by 38
Activation of CD 4+ F oxp3+ regulatory T cells proceeds normally in the absence of B cells during EAE
Hoehlig, K., Shen, P., Lampropoulou, V., Roch, T., MALISSEN, B., O’Connor, R. A., Ries, S., Hilgenberg, E., Anderton, S. M., & Fillatreau, S. (2012) · European Journal of Immunology · doi:10.1002/eji.201142242 · Cited by 40
The astrocytic response in early experimental autoimmune encephalomyelitis occurs across both the grey and white matter compartments.
Pham, H., Ramp, A. A., Klonis, N., Ng, S. W., Klopstein, A., Ayers, M., & Orian, J. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.12.010 · Cited by 33
Cannabinoids and experimental models of multiple sclerosis
Kubajewska, I., & Constantinescu, C. S. (2009) · Immunobiology · doi:10.1016/j.imbio.2009.08.004 · Cited by 37
Carbamylated erythropoietin to treat neuronal injury: new development strategies
Lapchak, P. A. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.8.1175 · Cited by 37
Regulation of central nervous system autoimmunity by the aryl hydrocarbon receptor
Quintana, F. J. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0397-1 · Cited by 36
Hyperforin down-regulates effector function of activated T lymphocytes and shows efficacy against Th1-triggered CNS inflammatory-demyelinating disease
Cabrelle, A., Dell’Aica, I., Melchiori, L., Carraro, S., Brunetta, E., Niero, R., Scquizzato, E., D’Intino, G., Calzà, L., Garbisa, S., et al. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0707469 · Cited by 36
Identification of Cellular Infiltrates during Early Stages of Brain Inflammation with Magnetic Resonance Microscopy
Waiczies, H., Millward, J. M., Lepore, S., Infante‐Duarte, C., Pohlmann, A., Niendorf, T., & Waiczies, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032796 · Cited by 37
Aggravated experimental autoimmune encephalomyelitis in IL-15 knockout mice
Gómez‐Nicola, D., Spagnolo, A., Guaza, C., & Nieto‐Sampedro, M. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2009.12.034 · Cited by 35
Suppression of neuroinflammation by an allosteric agonist and positive allosteric modulator of the α7 nicotinic acetylcholine receptor GAT107
Mizrachi, T., Marsha, O., Brusin, K., Ben‐David, Y., Thakur, G. A., Vaknin‐Dembinsky, A., Treinin, M., & Brenner, T. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02149-4 · Cited by 35
Modelling MS: Chronic-Relapsing EAE in the NOD/Lt Mouse Strain
Dang, P. T., Bui, Q., D’Souza, C. S., & Orian, J. M. (2015) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2015_378 · Cited by 35
The potential role of T cell migration and chemotaxis as targets of glucocorticoids in multiple sclerosis and experimental autoimmune encephalomyelitis
Fischer, H. J., Schweingruber, N., Lühder, F., & Reichardt, H. M. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.04.001 · Cited by 34
Dimethyl fumarate inhibits integrin α4 expression in multiple sclerosis models
Kihara, Y., Groves, A., Rivera, R. R., & Chun, J. J. M. (2015) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.251 · Cited by 34
Overexpression of the Dominant-Negative Form of Interferon Regulatory Factor 1 in Oligodendrocytes Protects against Experimental Autoimmune Encephalomyelitis
Ren, Z., Wang, Y., Tao, D., Liebenson, D., Liggett, T., Goswami, R., Clarke, R. C., Stefoski, D., & Balabanov, R. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.1028-11.2011 · Cited by 34
Bowman–Birk inhibitor suppresses autoimmune inflammation and neuronal loss in a mouse model of multiple sclerosis
Touil, T., Ćirić, B., Ventura, E. S., Shindler, K. S., Gran, B., & Rostami, A. M. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.04.030 · Cited by 33
Deep gray matter T2 hypointensity correlates with disability in a murine model of MS
Pirko, I., Johnson, A. J., Lohrey, A. K., Chen, Y., & Ying, J. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.12.013 · Cited by 32
Methylprednisolone induces reversible clinical and pathological remission and loss of lymphocyte reactivity to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis
Chan, J. M. K., Chan, J. M. K., Ban, E. J., Chan, J. M. K., Ban, E. J., Chun, K. H., Chan, J. M. K., Ban, E. J., Chun, K. H., Wang, S., et al. (2008) · Autoimmunity · doi:10.1080/08916930802011258 · Cited by 32
Double Roles of Macrophages in Human Neuroimmune Diseases and Their Animal Models
Fan, X., Zhang, H., Cheng, Y., Jiang, X., Zhu, J., & Jin, T. (2016) · Mediators of Inflammation · doi:10.1155/2016/8489251 · Cited by 34
A STAT3 inhibitor ameliorates CNS autoimmunity by restoring Teff:Treg balance
Aqel, S. I., Yang, X. T., Kraus, E. E., Song, J., Farinas, M. F., Zhao, E. Y., Pei, W., Lovett‐Racke, A. E., Racke, M. K., Li, C., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.142376 · Cited by 32
Enhancing the ability of experimental autoimmune encephalomyelitis to serve as a more rigorous model of multiple sclerosis through refinement of the experimental design.
Emerson, M. R., Gallagher, R. J., Marquis, J. G., & LeVine, S. M. (2009) · PubMed Central · Cited by 32
Kirenol Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Differentiation of Th1 and Th17 Cells and Inducing Apoptosis of Effector T Cells
Xiao, J., Yang, R., Yang, L., Fan, X., Liu, W., & Deng, W. (2015) · Scientific Reports · doi:10.1038/srep09022 · Cited by 32

Authors: Steinman, L., & Zamvil, S. S.
Affiliations: Stanford University (US)
University of California, San Francisco (US)
Corresponding author: Steinman, Lawrence
ORCID: Steinman, Lawrence
Zamvil, Scott S.
Venue: Annals of Neurology
Publisher: Wiley
Published: 2006-06-26
Volume: 60
Issue: 1
Pages: 12-21
ISSN: 0364-5134 (ISSN-L)
1531-8249
DOI: 10.1002/ana.20913
OpenAlex: W2140830894
Cited by: 479
References: 88
Citations by year: 2026: 5 · 2025: 6 · 2024: 6 · 2023: 9 · 2022: 23 · 2021: 18 · 2020: 17 · 2019: 17 · 2018: 13 · 2017: 19 · 2016: 22 · 2015: 23 · 2014: 29 · 2013: 44 · 2012: 37
FWCI: 5.49
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: Annals of Neurology (publishedVersion)
PubMed (publishedVersion)
Funders: Multiple Sclerosis Society
National Institute of Allergy and Infectious Diseases (R01AI059709)
Topics: Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
Keywords: experimental autoimmune encephalomyelitis, multiple sclerosis, animal models of disease, translational research, glatiramer acetate, mitoxantrone, natalizumab, MS pathogenesis, surrogate markers, preclinical drug development
MeSH terms: Animals, Disease Models, Animal, Encephalomyelitis, Autoimmune, Experimental, Humans, Multiple Sclerosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks